Anybody can develop a deep vein thrombosis (DVT). It's a serious public health issue. But some are more likely to get this clot – or even die from it – than others due to differences in treatment.

The patent’s assignee is Continuous Motionflow, Llc. News editors obtained the following quote from the background information supplied by the inventors: “It is estimated that more than a million ...

The mainstay of treatment for DVT is anticoagulation therapy. However, optimal anticoagulation strategies for cancer patients with isolated distal DVT are not currently established. ONCO DVT was the ...

If the choice is made to anticoagulate patients with symptomatic isolated distal deep vein thrombosis (DVT), outcomes will be improved with 12 versus 6 weeks of treatment, the randomized, ...

Deep vein thrombosis, or DVT, is a potentially life-threatening blood clotting condition. If you’ve ever had DVT or been at risk for this condition, you’ve likely been given drugs to help break up the ...

O’Sullivan is an interventional radiologist — a physician who specializes in minimally invasive, targeted treatments. In mid-March at the Society of Interventional Radiology scientific meeting in ...

Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ...

Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after ...

BEND, Ore.--(BUSINESS WIRE)--Inovia Vein Specialty Centers, a leading provider of vein disease treatments and therapies in the Pacific Northwest, announces its successful outreach and awareness ...

A study presented today shows that a combination of clot busting drugs infused directly into the clot is an effective interventional radiology technique to treat deep vein thrombosis by breaking up ...